Together Pharma Ltd (TLV:TGTR)
223.50
+1.70 (0.77%)
Aug 21, 2026, 1:44 PM IDT
Together Pharma Market Cap
Together Pharma has a market cap or net worth of 38.77 million as of August 21, 2026. Its market cap has decreased by -44.11% in one year.
Market Cap
38.77M
Enterprise Value
88.41M
Revenue
109.63M
Ranking
n/a
PE Ratio
18.63
Stock Price
223.50
ChartMarket Cap Chart
Since September 24, 2012, Together Pharma's market cap has decreased from 40.78M to 38.77M, a decrease of -4.92%. That is a compound annual growth rate of -0.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 38.77M | -33.26% |
| Dec 31, 2025 | 58.09M | 7.36% |
| Dec 31, 2024 | 54.11M | 58.74% |
| Dec 31, 2023 | 34.09M | 82.59% |
| Dec 29, 2022 | 18.67M | -72.51% |
| Dec 30, 2021 | 67.91M | -50.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 130.06B |
| Danel (Adir Yeoshua) | 2.53B |
| Amal Holdings A.D. | 2.32B |
| BrainsWay | 1.81B |
| Almeda Ventures Limited Partnership | 45.50M |
| BioLineRx | 41.94M |
| Clal Biotechnology Industries | 37.96M |
| Merchavia Holdings and Investments | 34.94M |